Ultrasensitive Protein Detection (USPD)
Targeted Biomarker Detection (Neurological/Inflammatory Diseases)
DevelopmentTechnology Access Program / Partnership Exploration
Key Facts
Indication
Targeted Biomarker Detection (Neurological/Inflammatory Diseases)
Phase
Development
Status
Technology Access Program / Partnership Exploration
Company
About Quantum SI
Founded in 2013 by Jonathan Rothberg, Quantum-Si is on a mission to power the post-genomic era by democratizing single-molecule protein analysis. Its flagship Platinum Pro instrument and associated kits provide a streamlined workflow for applications ranging from protein identification and variant detection to antibody characterization and ultrasensitive protein detection. As a public company, Quantum-Si is positioned to transform proteomics research and drug development by offering a scalable, benchtop-friendly alternative to mass spectrometry and immunoassays.
View full company profile